Product Reports Resources Pricing Login Book a demo

BioLiberty

Health Tech & Medtech · Edinburgh, United Kingdom · Founded 2020

Soft robotic glove for stroke rehabilitation therapy MoreLess

BioLiberty is a medical technology company founded in 2020 by Rowan Armstrong, Ross O'Hanlon, Shea Quinn, and Conan Bradley. The founders, alumni of the University of Edinburgh's MEng program, were inspired to start the company after one of them witnessed a family member with multiple sclerosis struggle with hand weakness. The firm is headquartered in Edinburgh, Scotland, at the National Robotarium, with a U.S. base in Boston.

The company develops soft robotic wearables and gamified digital therapy platforms to assist individuals with mobility-limiting conditions, initially focusing on stroke survivors. Its flagship product is the "Lifeglov," a soft robotic glove that assists patients with opening and closing their hand, combined with a digital therapy platform that provides tailored exercises and tracks metrics like range of motion and force. This system, known as Lifehub Clinic, is designed for use in clinical settings to deliver high-intensity, engaging therapy. It is powered by air and uses AI algorithms to provide controlled assistance calibrated to the patient's ability, with the goal of promoting neuroplasticity. The accompanying "Lifemind" software suite gives therapists insights into patient progress and will use AI to personalize treatments and streamline documentation for reimbursement.

BioLiberty's business model targets rehabilitation clinics and healthcare professionals, providing tools for remote patient management and improved outcomes. The company generates revenue through the sale of its FDA-registered Lifehub and Lifeglov products. Having secured significant funding, including a £2.2 million round led by Archangels and a subsequent £435,000 from Innovate UK, the company is focused on commercial expansion in the U.S. and UK markets and has initiated clinical studies with partners like the Mount Sinai Health System. While the initial focus is on upper-limb therapy for stroke patients, BioLiberty plans to expand its technology to other conditions and lower-limb applications.

Keywords: soft robotics, stroke rehabilitation, robotic glove, digital therapy, upper limb mobility, neuro-rehabilitation, assistive technology, medical wearables, physical therapy, occupational therapy, medtech, Lifeglov, remote patient monitoring, gamified therapy, hand weakness, neuroplasticity, telerehabilitation, mobility assistance, clinical rehabilitation, FDA registered device

Talent graph

BioLiberty's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on BioLiberty's cap table

Sourced from Dealroom's funding and investor records.

Seed 7 investors entered at this stage
CO-FOUNDERS
Catalyst Belfast Fintech Hub
Scottish Enterprise Growth Investments
Archangels
Eos Advisory
Hanna Capital SEZC
Edinburgh Innovations
Series A 4 investors entered at this stage
University of Edinburgh
Scottish National Investment Bank
Old College Capital
The Conduit Connect

Global footprint

Where BioLiberty has talent and traffic

Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom67.9%
🇺🇸 United States32.1%
2 countries shown

Market sentiment

What the market is saying about BioLiberty

An AI-synthesized read of the highest-engagement posts about BioLiberty on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioLiberty on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.